Kenyan Teenage Opera Singer Successfully Treated for Rare Brain Tumor by HCG
Diagnosed with Pineal Gland Tumor, till date only 12 cases reported worldwide
Bangalore, India, September 25, 2010 --(PR.com)-- HealthCare Global Enterprises Limited (HCG), South Asia’s largest cancer care network pioneering treatment of highly complicated and recurrent cases of cancer among patients from across the globe, today presented a case study of an opera singer from Africa who was successfully treated for a rare brain tumor – Pineal Gland Tumor.
Seraphine Moipei, a 14 year old girl from Kenya, Africa, started losing memory and became very forgetful. She would go to the kitchen and forget why she was there; she would start losing track of where she was and remained in the bathroom for hours together forgetting she was in the bathroom. Also she put on 18 kgs in less than nine months as she would eat at frequent intervals forgetting that she had just eaten.
Her worried parents consulted specialists in the African continent and still were left clueless about the nature of her disorder. It was at this time, that their well wishers suggested that they explore medical options in India and directed them to HCG.
On studying her reports HCG specialists concluded that it was a rare disorder and advised Seraphine’s parents to fly her on an emergency basis to Bangalore for a detailed investigation. On her arrival, HCG team led by Dr. B S Ajaikumar, Chairman, HCG put her through several tests and based on the reports concluded that Seraphine was suffering from Pineal Gland Tumor.
Commenting on the Seraphine case, Dr Ajaikumar said, “It was satisfying to put our expertise to test especially when doctors from other countries had no clue of the nature of disorder. This case study gives us the confidence that we could handle more complicated cases from around the world and make our vision of ‘living with cancer’ a reality.”
Elaborating on the nature of disorder and treatment provided to Seraphine, Dr P S Sridhar, Radiation Oncologist, HCG, said, “Detailed examination revealed that the patient was suffering from one of the rare brain tumor known as pineal gland tumor. Till date only 12 cases of this tumor have been reported worldwide. Given the nature of disorder and complexity involved, we operated upon Seraphine and successfully removed the tumor and also put her through two sessions of Cyberknife treatment”.
Seraphine’s mother Christine Moipei even while thanking HCG’s doctors said she was glad that the disorder has been successfully treated. She is elated that her daughter could soon start singing as the voice box is back to normal. Opera singing was her passion and she was extremely talented at that, Christine averred.
About HCG:
HealthCare Global Enterprises Ltd. (HCG), a leader in oncology care in India, currently manages a network of 18 cancer centres across South Asia. HCG focuses on cancer treatment centres, imaging & laboratory services and clinical trials & research services. The vision of HCG is to provide high quality, integrated, comprehensive cancer treatment to all segments of society. Bangalore Institute of Oncology (BIO), the flagship of HCG, set up almost 2 decades back was the first dedicated comprehensive cancer centre to be established in the private sector in India. Under the guidance of Dr. B.S. Ajaikumar, BIO acquired Curie Centre of Oncology in 2000 and re-christened it as HealthCare Global Enterprises Ltd.
###
Seraphine Moipei, a 14 year old girl from Kenya, Africa, started losing memory and became very forgetful. She would go to the kitchen and forget why she was there; she would start losing track of where she was and remained in the bathroom for hours together forgetting she was in the bathroom. Also she put on 18 kgs in less than nine months as she would eat at frequent intervals forgetting that she had just eaten.
Her worried parents consulted specialists in the African continent and still were left clueless about the nature of her disorder. It was at this time, that their well wishers suggested that they explore medical options in India and directed them to HCG.
On studying her reports HCG specialists concluded that it was a rare disorder and advised Seraphine’s parents to fly her on an emergency basis to Bangalore for a detailed investigation. On her arrival, HCG team led by Dr. B S Ajaikumar, Chairman, HCG put her through several tests and based on the reports concluded that Seraphine was suffering from Pineal Gland Tumor.
Commenting on the Seraphine case, Dr Ajaikumar said, “It was satisfying to put our expertise to test especially when doctors from other countries had no clue of the nature of disorder. This case study gives us the confidence that we could handle more complicated cases from around the world and make our vision of ‘living with cancer’ a reality.”
Elaborating on the nature of disorder and treatment provided to Seraphine, Dr P S Sridhar, Radiation Oncologist, HCG, said, “Detailed examination revealed that the patient was suffering from one of the rare brain tumor known as pineal gland tumor. Till date only 12 cases of this tumor have been reported worldwide. Given the nature of disorder and complexity involved, we operated upon Seraphine and successfully removed the tumor and also put her through two sessions of Cyberknife treatment”.
Seraphine’s mother Christine Moipei even while thanking HCG’s doctors said she was glad that the disorder has been successfully treated. She is elated that her daughter could soon start singing as the voice box is back to normal. Opera singing was her passion and she was extremely talented at that, Christine averred.
About HCG:
HealthCare Global Enterprises Ltd. (HCG), a leader in oncology care in India, currently manages a network of 18 cancer centres across South Asia. HCG focuses on cancer treatment centres, imaging & laboratory services and clinical trials & research services. The vision of HCG is to provide high quality, integrated, comprehensive cancer treatment to all segments of society. Bangalore Institute of Oncology (BIO), the flagship of HCG, set up almost 2 decades back was the first dedicated comprehensive cancer centre to be established in the private sector in India. Under the guidance of Dr. B.S. Ajaikumar, BIO acquired Curie Centre of Oncology in 2000 and re-christened it as HealthCare Global Enterprises Ltd.
###
Contact
HealthCare Global Enterprises Ltd.
Jinoop J S
9108040206000
http://hcgoncology.com
Jinoop J S
9108040206000
http://hcgoncology.com
Contact
Categories